| This week's sponsor is Pfizer CentreOne. | | | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, April 3, 2018 Each year, dozens of branded pharmaceutical products lose their legal lock on the market, paving the way for cheap generic competitors and the sales hit they bring—and for patients, pricing relief in costly drug categories. This year is no different, featuring some serious sales heft and household names at the top of the list. |
|
|
Top Stories Of The Week Friday, March 30, 2018 Eli Lilly is doubling down on novel mechanisms of action to steer clear of the “pile-on effect” seen in PD-1/PD-L1 and other hot targets. The Big Pharma wants to hightail novel approaches into the clinic and up to proof of concept before its rivals—and then kill off programs that fail to wow in phase 2. Tuesday, April 3, 2018 After selling Kite Pharma off to Gilead for $11.9 billion, former executives Arie Belldegrun and David Chang are working on allogeneic, or off-the-shelf, CAR-T treatments. Thursday, April 5, 2018 After Takeda revealed last week that it was eyeing a Shire buy, industry watchers expressed skepticism that the company could pull it off. Now, though, some analysts like the Japanese drugmaker’s chances. Monday, April 2, 2018 Johnson & Johnson and Bayer joined more than a dozen consumer brand advertisers last week in dropping out of Fox news show “The Ingraham Angle.” The brands—including Nestle, Trip Advisor, Office Depot and Wayfair—canceled media buys on the weekday show after host Laura Ingraham made fun of Marjorie Stoneman Douglas High School student David Hogg over several college rejections. Monday, April 2, 2018 French President Emmanuel Macron has committed to investing $1.8 billion in artificial intelligence over the next four years. The spending plan will target the healthcare sector and is accompanied by a commitment to open up French data. Thursday, March 29, 2018 Switching on the LZK gene in mice with spinal cord injuries resulted in a smaller scar, which UT Southwestern researchers hope will improve recovery. Wednesday, April 4, 2018 If its universal flu vaccine succeeds in phase 3, BiondVax aims to hustle to the European market, CEO Ron Babecoff said. Thursday, April 5, 2018 Apple has officially launched its Apple Health Records function, which allows users to access EHRs from multiple healthcare providers in one place—and it could change the clinical trial landscape in many ways. Thursday, April 5, 2018 Fujifilm continues to expand its healthcare footprint with the recent acquisition of a pair of cell culture media units from Japan’s JXTG Holdings for about $800 million. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Halo Pharma Why does confidence matter when outsourcing Fixed-Dose Combination products? Download Halo Pharma’s white paper on the importance of product design, technology, and analyticals tools for FDC. Sponsored by: WCG Small biopharma companies are conducting almost 50% of the clinical trials in the US today, yet they face unique challenges that large pharma do not. In this paper, we explore some of those challenges, and solutions that can reduce the pressure on small biopharma teams and timelines. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Sponsored by: DocuSign Life science companies are experiencing a significant transformation in how they bring new products to market. |
